AstraZeneca PLC
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
What If You Bought AZN Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jul 27, 2015 | $131.52 | 2-for-1 | 2× | 6× |
| Apr 8, 1998 | $279.38 | 3-for-1 | 3× | 3× |
AstraZeneca PLC Market Cap Timeline
Market capitalization is available from 1996; the sourced public-listing year is 1993, so earlier annual values remain unavailable. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.